中美史克

Zhongmei Tianjin Smith Kline & French Laboratories Ltd., commonly known as 中美史克, is a leading pharmaceutical joint venture in China established in 1987. The company was formed between SmithKline Beckman (now Haleon) and Tianjin Pharmaceutical Group and has become a dominant player in the Chinese over-the-counter (OTC) market. Its product portfolio features several of China's most recognized consumer brands, including Fenbid for pain relief, Contac for respiratory health, and Zentel for parasitic infections. Following the global demerger of GSK's consumer healthcare business in 2022, the company now operates under the Haleon corporate umbrella. The firm operates a major manufacturing base in Tianjin that adheres to international GMP standards. With a focus on pain management, respiratory health, and skin care, 中美史克 continues to be a key driver of healthcare accessibility in the region.